Norovirus Costs the U.S. $10.6 Billion a Year

The Headline Figure

A 2020 analysis by Bartsch et al., published in the Journal of Infectious Diseases (vol. 222, issue 11, DOI: 10.1093/infdis/jiaa292), estimated the total annual U.S. societal cost of norovirus at approximately $10.6 billion. The structure of that cost is striking:

~89% Productivity losses
(missed work, caregiving, premature death)

~11% Direct medical costs
(visits, hospitalization, treatment)

The productivity-dominated cost structure — where indirect losses from missed workdays swamp direct medical spending — makes norovirus economically unlike most other infectious diseases, where health-system costs are the primary driver. This pattern holds because norovirus is highly contagious, nearly universal in incidence, usually self-limiting (so formal medical care is often not sought), and concentrated in economically active populations.

Adults aged 45 and older account for more than half of total productivity losses, per the Bartsch 2020 analysis — reflecting both higher workforce participation in that cohort and the greater severity of norovirus illness in older adults.

What the headline figure implies per illness — and where two estimates diverge

Set $10.6 billion against the CDC's estimate of 19–21 million US illnesses a year and the societal cost is on the order of $500–560 per illness ($10.6 billion ÷ 21 million ≈ $505; ÷ 19 million ≈ $558 — our arithmetic from the two published figures). Most of that is a day or two of lost work or caregiving, not a medical bill, which is consistent with the 89/11 split above.

The direct-medical slice is where sources differ, and it is worth saying so. Bartsch 2020's ~11% direct-cost share implies roughly $1.2 billion a year in medical costs. A separate CDC-authored study, Burke et al. 2021 (Clinical Infectious Diseases, DOI 10.1093/cid/ciaa438), which estimated the 109,000 hospitalizations and 465,000 emergency-department visits the CDC now cites, put the associated healthcare charges at $430–740 million. The two are not measuring the same thing — billed charges over 2001–2015 versus modeled costs in a single reference year — but a reader comparing "norovirus medical costs" figures across sources should expect to see anything from about $0.4 billion to $1.2 billion, and should ask which definition is in use.

The Foodborne Slice: $2–3 Billion Per Year

Not all norovirus transmission is foodborne — person-to-person spread is in fact the dominant route, particularly in institutional settings. But the foodborne component has its own, separately quantified economic burden, and two federal estimates bracket it:

The CDC estimates that foodborne norovirus illness costs the U.S. about $2 billion per year, mainly from lost productivity and healthcare expenses.
The USDA Economic Research Service (USDA ERS) ranks norovirus among the top five foodborne pathogens by annual economic cost — approximately $2.97 billion (in 2023 dollars) across an estimated 5.46 million foodborne cases. Source: USDA ERS, Cost Estimates of Foodborne Illnesses.

The foodborne cost falls disproportionately on the food service industry, which faces direct costs from contamination events (discarded food, facility cleaning and closure, staff illness) and indirect costs from reputational damage and consumer avoidance following publicly reported outbreaks.

Outbreak Settings and Their Specific Costs

Norovirus outbreaks cluster in settings where people eat communally, share close quarters, or both. Each setting has a distinct economic profile: The per-outbreak figures for each — derived from CDC outbreak sizes, published per-illness costs and the few real disclosures — are on our outbreak cost page.

Cruise ships

Cruise-ship norovirus outbreaks are among the most visible because CDC Vessel Sanitation Program data are public, and media coverage is extensive. The economic costs include: health-care provision on board, early debarkation of ill passengers, partial-voyage refunds, accelerated deep cleaning between voyages, and the reputational effect on future bookings. The CDC has documented dozens of cruise outbreaks per year in U.S.-accessible waters.

Long-term care facilities

Nursing homes and assisted-living facilities are the highest-severity norovirus setting. Older adults in congregate care face higher hospitalization rates from norovirus than the general population; outbreak response involves cohorting ill residents, staff reassignment, visitor restriction, and the direct and indirect costs of increased nursing intensity. Norovirus is the leading cause of acute gastroenteritis outbreaks in long-term care settings, per CDC surveillance.

Schools and childcare

School-based norovirus outbreaks impose large productivity costs on parents who must leave work to care for sick children or pick them up early. A single school outbreak affecting hundreds of students can result in thousands of aggregate parent-workday losses — a cost that never appears in health-system data but is real and significant.

Food service and restaurants

Infected food handlers are a primary vector for restaurant-linked outbreaks. Outbreak investigations regularly trace norovirus transmission to a single symptomatic employee who worked while ill — a behavior driven partly by lack of paid sick leave. The economic cost of this pathway includes the outbreak response, liability exposure, and the lasting reputational impact on the establishment.

Global Economic Burden

A 2016 analysis by Bartsch et al. in PLOS ONE (DOI: 10.1371/journal.pone.0151219) estimated the global annual economic burden of norovirus gastroenteritis at approximately $4.2 billion in direct health-system costs (95% UI: $3.2–5.7B) and $60.3 billion in total societal costs including productivity losses (95% UI: $44.4–83.4B).

The gap between U.S. and global figures illustrates a familiar pattern in infectious-disease economics: the U.S. per-case cost is high because of high health-system prices and high nominal wages (making productivity losses expensive in dollar terms). Low-income countries bear substantial norovirus burden — it is one of the leading causes of childhood diarrheal disease globally — but the dollar-denominated economic cost appears smaller because wages and health-system costs are lower. Burden measured in disability-adjusted life years (DALYs) rather than dollars would show a different distribution.

Sources & References

Bartsch SM et al. Clinical and Economic Burden of Norovirus Gastroenteritis in the United States. Journal of Infectious Diseases. 2020;222(11):1910–1919. DOI: 10.1093/infdis/jiaa292
Bartsch SM et al. Global Economic Burden of Norovirus Gastroenteritis. PLOS ONE. 2016;11(4):e0151219. DOI: 10.1371/journal.pone.0151219
USDA Economic Research Service. Cost Estimates of Foodborne Illnesses. ers.usda.gov
CDC. Norovirus Facts and Stats. cdc.gov/norovirus/data-research
Burke RM, Mattison CP, Pindyck T, et al. Burden of Norovirus in the United States, as Estimated Based on Administrative Data: Updates for Medically Attended Illness and Mortality, 2001–2015. Clinical Infectious Diseases. 2021;73(1):e1–e8. DOI: 10.1093/cid/ciaa438
CDC Vessel Sanitation Program. Outbreaks on Cruise Ships in VSP's Jurisdiction. cdc.gov/vessel-sanitation

Andy Wilcox

Andy Wilcox brings 30+ years of business and financial analysis to this research — including management consulting at Ernst & Young, angel investing in life-sciences ventures at Triangle Angel Partners, and quantitative economic modeling. He is an independent researcher, not a physician, and nothing here is medical advice.

Last reviewed: September 2026